Literature DB >> 17652386

Primary isolates of human immunodeficiency virus type 1 are usually dominated by the major variants found in blood.

Yegor Voronin1, Bhavna Chohan, Michael Emerman, Julie Overbaugh.   

Abstract

The isolation of primary strains of human immunodeficiency virus (HIV) is an invaluable tool for assessing properties of viruses replicating in HIV-infected subjects. A common method for obtaining a primary isolate is coculture of peripheral blood mononuclear cells (PBMCs) from HIV-infected subjects with PBMCs from uninfected donors. However, such in vitro expansion may disturb the composition (identities and relative proportions of constituting viral species) of the original viral population. We developed a GeneScan assay to monitor HIV populations by detecting variants that differ in the length of the V1/V2 coding region of the envelope gene. This assay was used to compare proviral DNAs from the PBMCs of eight subjects to the corresponding primary isolates. Major variants found in uncultured PBMCs usually persisted during culturing, while the minor variants frequently disappeared, resulting in a reduction in viral diversity. The outgrowth of the initial (2 to 4 days) viral population appeared to be determined by random events. However, subsequent changes in the population were deterministic, and as a result, the compositions of primary isolates from parallel cultures were often very similar. For two of three subjects studied, the source of HIV-negative PBMCs had little effect on the composition of primary isolates, while for the third subject donor-dependent effects were observed. Overall, our results show that most primary isolates accurately represent the major viruses found in a subject's blood and that rapid population-based genotyping methods are useful for detecting isolates with perturbed viral populations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652386      PMCID: PMC2045467          DOI: 10.1128/JVI.01035-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from Uganda.

Authors:  Alexandra M Klevytska; Martin R Mracna; Laura Guay; Graziella Becker-Pergola; Manohar Furtado; Linqi Zhang; J Brooks Jackson; Susan H Eshleman
Journal:  AIDS Res Hum Retroviruses       Date:  2002-07-20       Impact factor: 2.205

2.  Procedures for reliable estimation of viral fitness from time-series data.

Authors:  Sebastian Bonhoeffer; Andrew D Barbour; Rob J De Boer
Journal:  Proc Biol Sci       Date:  2002-09-22       Impact factor: 5.349

3.  Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy.

Authors:  L Zhang; C Chung; B S Hu; T He; Y Guo; A J Kim; E Skulsky; X Jin; A Hurley; B Ramratnam; M Markowitz; D D Ho
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

4.  Fitness landscape of human immunodeficiency virus type 1 protease quasispecies.

Authors:  Guerau Fernàndez; Bonaventura Clotet; Miguel Angel Martínez
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

5.  Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes.

Authors:  J M Carr; H Hocking; P Li; C J Burrell
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

6.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

Review 7.  Fitness of drug resistant HIV-1: methodology and clinical implications.

Authors:  Miguel E Quiñones-Mateu; Eric J Arts
Journal:  Drug Resist Updat       Date:  2002-12       Impact factor: 18.500

8.  Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.

Authors:  Alexey A Nabatov; Georgios Pollakis; Thomas Linnemann; Aletta Kliphius; Moustapha I M Chalaby; William A Paxton
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

9.  Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection.

Authors:  Kathryn M Kitrinos; Noah G Hoffman; Julie A E Nelson; Ronald Swanstrom
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression.

Authors:  Silvina Masciotra; Sherry M Owen; Donna Rudolph; Chunfu Yang; Bin Wang; Nitin Saksena; Thomas Spira; Subhash Dhawan; Renu B Lal
Journal:  AIDS       Date:  2002-09-27       Impact factor: 4.177

View more
  13 in total

1.  Sensitivity changes over the course of infection increases the likelihood of resistance against fusion but not CCR5 receptor blockers.

Authors:  Nikolaos Chatziandreou; Ana Belen Arauz; Ines Freitas; Phyu Hninn Nyein; Gregory Fenton; Shruti H Mehta; Gregory D Kirk; Manish Sagar
Journal:  AIDS Res Hum Retroviruses       Date:  2012-06-25       Impact factor: 2.205

2.  Single genome amplification and standard bulk PCR yield HIV-1 envelope products with similar genotypic and phenotypic characteristics.

Authors:  Behzad Etemad; Melissa Ghulam-Smith; Oscar Gonzalez; Laura F White; Manish Sagar
Journal:  J Virol Methods       Date:  2015-02-11       Impact factor: 2.014

3.  HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype.

Authors:  Jennifer Mabuka; Leslie Goo; Maxwel M Omenda; Ruth Nduati; Julie Overbaugh
Journal:  AIDS       Date:  2013-06-19       Impact factor: 4.177

4.  HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response.

Authors:  Anne Piantadosi; Bhavna Chohan; Dana Panteleeff; Jared M Baeten; Kishorchandra Mandaliya; Jeckoniah O Ndinya-Achola; Julie Overbaugh
Journal:  AIDS       Date:  2009-03-13       Impact factor: 4.177

5.  Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates.

Authors:  Ashika Singh; Taryn Page; Penny L Moore; Rachel L Allgaier; Keshni Hiramen; Hoosen M Coovadia; Bruce D Walker; Lynn Morris; Thumbi Ndung'u
Journal:  Virology       Date:  2009-08-19       Impact factor: 3.616

6.  Genetic characterization of hepatitis B virus in peripheral blood leukocytes: evidence for selection and compartmentalization of viral variants with the immune escape G145R mutation.

Authors:  Sibnarayan Datta; Rajesh Panigrahi; Avik Biswas; Partha K Chandra; Arup Banerjee; Pradip K Mahapatra; Chinmoy K Panda; Shekhar Chakrabarti; Sujit K Bhattacharya; Kuntal Biswas; Runu Chakravarty
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 superinfection occurs despite relatively robust neutralizing antibody responses.

Authors:  Catherine A Blish; Ozge C Dogan; Nina R Derby; Minh-An Nguyen; Bhavna Chohan; Barbra A Richardson; Julie Overbaugh
Journal:  J Virol       Date:  2008-10-08       Impact factor: 5.103

8.  Comparison of human immunodeficiency virus type 1 tropism profiles in clinical samples by the Trofile and MT-2 assays.

Authors:  Eoin Coakley; Jacqueline D Reeves; Wei Huang; Marga Mangas-Ruiz; Irma Maurer; Agnes M Harskamp; Soumi Gupta; Yolanda Lie; Christos J Petropoulos; Hanneke Schuitemaker; Angélique B van 't Wout
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

9.  Low-replicating viruses and strong anti-viral immune response associated with prolonged disease control in a superinfected HIV-1 LTNP elite controller.

Authors:  María Pernas; Concepción Casado; Carolina Arcones; Anuska Llano; Víctor Sánchez-Merino; Beatriz Mothe; José L Vicario; Eulalia Grau; Lidia Ruiz; Jorge Sánchez; Amalio Telenti; Eloísa Yuste; Christian Brander; Cecilio López- Galíndez
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

10.  In-depth characterization of viral isolates from plasma and cells compared with plasma circulating quasispecies in early HIV-1 infection.

Authors:  Judith Dalmau; Francisco M Codoñer; Itziar Erkizia; Maria Pino; Christian Pou; Roger Paredes; Bonaventura Clotet; Javier Martinez-Picado; Julia G Prado
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.